T. Bauer (Berlin, Germany), S. Ott (Berlin, Germany), M. Sucena (Leca Da Palmeira, Portugal)
CURB65 versus PSI in assessing the severity of CAP of elderly patients
R. Peris Sánchez, E. Fernández-Fabrellas, A. Cervera, M. C. Aguar, J. Blanquer, E. Chiner, F. Sanz, M. L. Briones, J. N. Sancho-Chust, C. Senent (Valencia, Spain)
|  |
Role of angiopoietins Ang-1 and Ang-2 for the development of acute lung injury in pneumococcal pneumonia
B. Gutbier, K. Reppe, A. K. Neuhauss, A. Santel, J. Kaufmann, N. Weissmann, L. Morawitz, T. J. Mitchell, N. Suttorp, M. Witzenrath, The CAPNETZ Study Group (Berlin, Giessen, Hannover, Germany; Glasgow, United Kingdom)
| |
Differences between local and systemic inflammatory response in patients with community acquired pneumonia (CAP)
L. C. Morlacchi, S. Aliberti, S. Seghezzi, V. Giunta, F. Giuliani, S. Galbiati, B. Dallari, A. Gramegna, M. Di Pasquale, G. Spoletini, A. M. Brambilla, J. Bordon, F. Blasi (Milano, Monza, Italy; Washington, United States Of America)
|  |
Validity of CRB-65 in LRTI in primary care: A prospective study in 12 European countries
S. Coenen, T. Verheij, G. Ieven, C. Lammens, C. Butler, P. Little, H. Goossens, on Behalf of the GRACE Project Group (Antwerp, Belgium; Utrecht, Netherlands; Cardif, Southampton, United Kingdom)
| |
Vascular events following hospitalisation for community acquired pneumonia
A. R. Akram, J. D. Chalmers, A. Singanayagam, G. B. Fleming, J. K. Taylor, D. Mills, A. T. Hill (Edinburgh, United Kingdom)
| |
Clinical failure in hospitalized patients with community acquired pneumonia (CAP): Preliminary results from the FAILCAP study
S. Aliberti, L. Morlacchi, A. Gramegna, E. Parazzini, D. Stolz, L. Ruvolo, F. Karrer, G. Cervi, R. Cosentini, A. Zanaboni, A. Marruchella, E. Magni, P. Peyrani, A. Pesci, J. Ramirez, F. Blasi (Monza, Milan, San Donato Milanese, Modena, Italy; Basel, Switzerland; Louisville, United States Of America)
| |
Does it matter which set of observations are used to calculate the CURB65 score for pneumonia?
M. Gautam, K. Lyulcheva, Z. Estabragh, J. Naveed, P. Deegan (Liverpool, United Kingdom)
| |
Severe complicated pneumococcal pneumonia in young adults
S. Ellis, M. Harris, S. Shuttleworth, C. Taylor, A. A. Lwin (Southampton, United Kingdom)
| |
Role of pneumococcus urinary antigen testing in the clinical presentation and outcome of pneumococcal bacteraemic community acquired pneumonia
L. A. Ruiz, M. Alfonso, A. Gomez, S. Pedrero, N. Marina, M. Inchausti, I. Seijas, C. Jaca, R. Zalacain (Barakaldo, Spain)
| |
Is pneumonia in elderly an enigma: A study from a multispecialty hospital in rural India
B. N. B. M. Prasad, C. A. Tukaram (Wellington Barracks, The Nilgiris District, India)
| |
Prospective comparison between chest ultrasound and X-ray in two planes in patients with suspected community-acquired pneumonia. Intermediate results (02/2011) of a prospective multicenter DEGUM-/ÖGUM-study
A. Reissig, C. Mempel, R. Copetti, A. Schuler, S. Aliberti, P. Zechner, A. Heinzmann, R. Neumann, G. Mathis, C. Kroegel (Jena, Geislingen, Reutlingen, Germany; Tolmezzo, Milan, Italy; Graz, Rankweil, Austria)
| |
Does a clinical score helps in the management of hospital-acquired pneumonia in nonventilated patients?
B. Herer, Z. Gazevic (Férolles Attilly, France)
| |
Comparison of four systems for assessing severity of community acquired pneumonia
T. Abreu, T. Lopes, M. Anciães, D. Ferreira, S. Salgado, G. Duarte (Lisbon, Portugal)
| |
Value of serum procalcitonin levels in the differential diagnosis of pneumonia and pulmonary embolism
A. Yeter, G. Camsari, G. Ozkan, A. Gur, N. D. Bakan, M. Bayram (Istanbul, Turkey)
| |
The value of exhaled breath condensate ‘pH‘ to evaluate the severity of disease and the response to treatment in patients with community acquired pneumonia
D. Arik, C. Tasci, M. Ozkan, H. Bilgic, C. Acikel, I. Kurt (Ankara, Turkey)
| |
Cost and outcomes of pneumococcal community-acquired pneumonia among adults in the United Kingdom
A. Charos, P. Balmer (Walton Oaks, United Kingdom)
| |
Relationship between the presence of hypoxemia and the inflammatory response measured by C-reactive protein in bacteremic pneumococcal pneumonia
F. Sanz, C. Gimeno, T. Lloret, N. Tormo, M. Briones, E. Fernández, A. Cervera, M. C. Aguar, E. Chiner, J. Blanquer (Valencia, Alacant, Spain)
| |
Usefulness of serum cortisol in assessment for the severity of community-acquired pneumonia
M. S. Kim (Changwon, Republic Of Korea)
| |
Community acquired pneumonia in a Greek hospital: Adherence of Greek doctors to the IDSA/ATS and national guidelines
C. Triantafyllidis, V. Kapordelis, G. Papaetis, D. Orfanidou, M. Apostolidou, I. Nikolopoulos, A. Pefanis (Athens, Greece)
| |
Ventilator-associated pneumonia in surgical intensive care unit: Risk factors for mortality and survival period
H. Shoji, T. Takuma, K. Yoshida, Y. Niki (Tokyo, Japan)
| |